Lung Cancer
NSCLC of Upper Lobe of Right Lung
Male, 68 years
Patient Internal ID: 275816445
ICD-10 code
C45.0 Mesothelioma of Pleura
Diagnosis (Incl. Metastases/Stage) and Year
January 2020
Non-Small Cell Lung Carcinoma of the Upper Lobe of the Right Lung cT4N3M1 Stage IVb EGFR+. Metastases in the Left Lung, Abdominal Lymph Nodes, Liver, Adrenal Glands, Brain and Bones.
Previous Treatment
Target Therapy (Afatinib), Radiation Therapy, Gama Knife, Chemotherapy (Cisplatin and Pemetrexed), Chemotherapy (Docetaxel and Nintedanib).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of 16 months and the 5-year relative survival rate is about 9%.
Treatment Provided
Autologous DCV (6 doses) and CIK (4 doses) over a period of 4 months.
Patient Survival/Condition and Year
Date of Review: 15/10/2023
The patient has survived for 22 months. It can be concluded that the addition of Immunotherapy, alongside Target therapy, Radiation Therapy and Chemotherapy, has extended patient survival by an estimate of 8 months.
